Bortezomib-Based Regimens for Newly Diagnosed Multiple Myeloma in China: A Report of 12-Year Real-World Data

Background: Improve the treatment quality might affect patients’ efficacy and survival. Methods: Five hundred thirty multiple myeloma patients treated in four hematological centers in China from February 2006 to August 2018 were enrolled. General characteristics, treatment regimens and cycles, effic...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jingsong, He, Donghua, Han, Xiaoyan, Zheng, Gaofeng, Wei, Guoqing, Zhao, Yi, Yang, Yang, Wu, Wenjun, Fu, Jiaping, Shou, Lihong, Kong, Hongwei, Huang, He, Cai, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759685/
https://www.ncbi.nlm.nih.gov/pubmed/33362538
http://dx.doi.org/10.3389/fphar.2020.561601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759685/
https://www.ncbi.nlm.nih.gov/pubmed/33362538
http://dx.doi.org/10.3389/fphar.2020.561601

Ejemplares similares